ENKAM PHARMACEUTICALS ApS: Financial statements 2014
CVR: 25812921
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,669,049 and a net result of DKK 2,812,225 compared with DKK -3,665,105 the year before. Equity amounted to DKK -1,918,271.
- Gross Profit
- 4,669,049 kr.
- Profit/Loss
- 2,812,225 kr.
- Equity
- -1,918,271 kr.
- Total Assets
- 1,281,268 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.7 mio. | 2.8 mio. | -1.9 mio. | - |
| 2013 | - | -2.6 mio. | -3.7 mio. | -4.7 mio. | - |
| 2012 | - | -1.1 mio. | -2.5 mio. | -3.5 mio. | - |
Keep an eye on ENKAM PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
ENKAM PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK -2,621,140, and the net result was DKK -3,665,105.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 0 employees. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity amounted to DKK -1,179,474.
